5
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Gastro-Oesophageal Reflux during 3 Months of Therapy with Ranitidine in Reflux Oesophagitis

&
Pages 954-958 | Received 28 Dec 1995, Accepted 15 Apr 1996, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Birgitte-Elise G. Emken, Lars R. Lundell, Lene Wallin, Helge E. Myrvold, Cecilia Engström, Madeleine Montgomery, Anders R. Malm, Tore Lind & Jan G. Hatlebakk. (2017) Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years. Scandinavian Journal of Gastroenterology 52:1, pages 11-17.
Read now

Articles from other publishers (19)

Naoki Chiba & M Brian Fennerty. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 17 61 .
K. Clark, L. Lam & D. Currow. (2009) Reducing gastric secretions—a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?. Supportive Care in Cancer 17:12, pages 1463-1468.
Crossref
K. Clark, L. T. Lam, S. Gibson & D. Currow. (2009) The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia 64:6, pages 652-657.
Crossref
P. O. KATZ, G. G. GINSBERG, P. E. HOYLE, M. B. SOSTEK, J. T. MONYAK & D. G. SILBERG. (2006) Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Alimentary Pharmacology & Therapeutics 25:5, pages 617-628.
Crossref
A. Rackoff, A. Agrawal, A. Hila, I. Mainie, R. Tutuian & D. O. Castell. (2005) Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Diseases of the Esophagus 18:6, pages 370-373.
Crossref
Michael Pettit. (2005) Treatment of Gastroesophageal Reflux Disease*. Pharmacy World & Science 27:6, pages 432-435.
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 13 54 .
Amarnath Ramakrishnan & Philip O Katz. (2003) Overview of medical therapy for gastroesophageal disease. Gastrointestinal Endoscopy Clinics of North America 13:1, pages 57-68.
Crossref
Amarnath Ramakrishnan & Philip O. Katz. (2002) Pharmacologic management of gastroesophageal reflux disease. Current Treatment Options in Gastroenterology 5:4, pages 301-310.
Crossref
Amarnath Ramakrishnan & Philip O. Katz. (2002) Pharmacologic management of gastroesophageal reflux disease. Current Gastroenterology Reports 4:3, pages 218-224.
Crossref
Javier P. Gisbert & José María Pajares. (2002) Prevalencia de la infección por Helicobacter pylori en la enfermedad por reflujo gastroesofágico y en el esófago de Barrett: revisión sistemática y metaanálisis. Medicina Clínica 119:6, pages 217-223.
Crossref
Philip O. Katz & Radu Tutuian. (2001) Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease. Best Practice & Research Clinical Gastroenterology 15:3, pages 371-384.
Crossref
Jia-Qing Huang & Richard H. Hunt. (2001) Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice & Research Clinical Gastroenterology 15:3, pages 355-370.
Crossref
Solomon Tefera, Jan Gunnar Hatlebakk & Arnold Berstad. (2001) Stability of Gastric Secretory Inhibition During 6-Month Treatment With Omeprazole in Patients With Gastroesophageal Reflux Disease. American Journal of Gastroenterology 96:4, pages 969-974.
Crossref
Richard A. Awad, Santiago Camacho & Miguel Dibildox. (2001) Pantoprazole Effectively Controls Intra-Oesophageal pH and Promotes Oesophageal Healing. Clinical Drug Investigation 21:4, pages 265-272.
Crossref
P. O. Katz. 2000. Helicobacter pylori. Helicobacter pylori 385 390 .
Jan G. Hatlebakk, Philip O. Katz & Donald O. Castell. (1999) MEDICAL THERAPY. Gastroenterology Clinics of North America 28:4, pages 847-860.
Crossref
Peters, Kuipers, Ganesh, Sluiter, Klinkenberg‐Knol, Lamers & Kleibeuker. (2001) The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy . Alimentary Pharmacology & Therapeutics 13:7, pages 921-926.
Crossref
Hatlebakk, Katz, Kuo & Castell. (2002) Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Alimentary Pharmacology & Therapeutics 12:12, pages 1235-1240.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.